Gaois

This is a static copy of data that is exported from IATE on an occasional basis. It should not be assumed that information provided about an entry here will always correspond to the current version of the entry in IATE. That current version can be checked by clicking on the link on the upper right hand side of each entry. More information »

1 result

  1. EUROPEAN UNION|EU institutions and European civil service|EU office or agency|European Medicines Agency · SOCIAL QUESTIONS|health|pharmaceutical industry|pharmaceutical product|medicament
    cógais tosaíochta Reference Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    scéim cógas tosaíochta Reference Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    PRIME Reference Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    Schema für prioritäre Arzneimittel | PRIME
    de
    Definition Schema zur Optimierung der Entwicklung prioritärer Arzneimittel und der Erleichterung des Zugangs für Patienten Reference "Europäische Kommission > Gesundheitswesen > Newsletter > 170 (25.3.2021):"
    priority medicines | PRIME | priority medicines scheme | PRIME scheme | PRIME priority medicines scheme
    en
    Definition "scheme run by the European Medicines Agency (EMA) to enhance support for the development of medicines that target an unmet medical need - for which no treatment option exists, or where they can offer a major therapeutic advantage over existing treatments" Reference "COM-Terminology Coordination, based on: European Medicines Agency (EMA). 'PRIME: priority medicines' (21.6.2023)"
    programme PRIME | programme en faveur des médicaments prioritaires
    fr
    Definition programme lancé par l’Agence européenne des médicaments, s’appuyant sur les outils réglementaires de l’UE destinés à accélérer le développement de médicaments ciblant des besoins médicaux non satisfaits Reference "COM-FR d'aprèsCommission européenne > Santé publique > Newsletter > 171 - La lutte contre les maladies rares nécessite une intense coopération (11.11.2021)"